BRIEF-Aveo Pharmaceuticals announced discontinuation of focal study By: Reuters: Company News September 12, 2016 at 06:22 AM EDT * Announced discontinuation of focal study, a phase 2, placebo controlled clinical study, evaluating ficlatuzumab Read More >> Related Stocks: Aveo Pharmaceuticals